133 related articles for article (PubMed ID: 6990569)
1. Reactivation of ocular malignant melanoma after renal transplantation.
Spees EK; Kramer KK; Light JA; Oakes DD; Zimmerman LE
Transplantation; 1980 May; 29(5):421-4. PubMed ID: 6990569
[No Abstract] [Full Text] [Related]
2. [Clinical use and results of immunodepressive treatment with anti-lymphocyte immunoglobulins in human renal allotransplantation].
Scotti-Foglieni C; Salvadeo A; Cortinovis R; Colombo P; Donati GS; Uggeri F; Magni M; Pedroni G; del Bulletti G Robustelli
Minerva Med; 1971 Sep; 62(70):3325-44. PubMed ID: 4939288
[No Abstract] [Full Text] [Related]
3. Medroxyprogesterone antilymphocyte globulin, prednisone, and azathioprine in the treatment of dog renal allografts.
MacDonald AS; Alexander JL; Busch GJ; Murray JE
Surg Forum; 1969; 20():306-7. PubMed ID: 4192215
[No Abstract] [Full Text] [Related]
4. Incidence of cytomegalovirus infections in renal transplant patients treated with conventional or cyclosporin therapy.
Guerin C; Pozzetto B; Genin C; Berthoux FC; Gaudin OG
Nephrol Dial Transplant; 1988; 3(1):77-80. PubMed ID: 2837679
[TBL] [Abstract][Full Text] [Related]
5. Brequinar sodium significantly reduces the incidence of steroid-resistant rejection and resource utilization in primary renal transplant patients compared with azathioprine.
Dunn JF; Hatch J; Precht A; Hart M; Li S
Transplant Proc; 1996 Apr; 28(2):955-7. PubMed ID: 8623479
[No Abstract] [Full Text] [Related]
6. Immunology in neoplasia relating to diagnosis, therapy and transplantation. Immunosuppression and oncogenesis.
Cerilli J; Hattan D
Am J Clin Pathol; 1974 Aug; 62(2):218-23. PubMed ID: 4602088
[No Abstract] [Full Text] [Related]
7. [Immunosuppressive therapy].
Nakamura H
Rinsho Byori; 1991 Jul; Suppl 90():102-14. PubMed ID: 1920848
[No Abstract] [Full Text] [Related]
8. Frequency of allograft renal vascular thrombosis under three immunosuppressive regimens at a single institution.
Gruber SA; Chavers B; Payne WD; Fryd DS; Canafax DM; Simmons RL; Najarian JS; Matas A
Transplant Proc; 1989 Feb; 21(1 Pt 2):2139-40. PubMed ID: 2652690
[No Abstract] [Full Text] [Related]
9. Case studies: conversion from Sandimmune to Neoral in stable renal allograft recipients.
Roth D; Miller J
Transplant Proc; 1996 Aug; 28(4):2219-20; discussion 2218. PubMed ID: 8769204
[No Abstract] [Full Text] [Related]
10. Thromboembolic complications after renal transplantation: results from the randomized trial of cyclosporine v azathioprine-antilymphocyte globulin.
Gruber SA; Pescovitz M; Simmons RL; Najarian JS; Ascher NL; Payne WD; Sutherland DE; Elick B; Fryd DS
Transplant Proc; 1987 Feb; 19(1 Pt 2):1815-6. PubMed ID: 3079041
[No Abstract] [Full Text] [Related]
11. Cardiac transplantation in man. II. Immunosuppressive therapy.
Stinson EB; Dong E; Bieber CP; Popp RL; Shumway NE
J Thorac Cardiovasc Surg; 1969 Sep; 58(3):326-37. PubMed ID: 4980410
[No Abstract] [Full Text] [Related]
12. Influence of immunosuppressive therapy on infectious complications in renal transplant recipients.
Klauser R; Zlabinger GJ; Traindl O; Franz M; Watschinger B; Pohanka E; Kudlacek S; Kovarik J
Transplant Proc; 1992 Feb; 24(1):292-4. PubMed ID: 1539284
[No Abstract] [Full Text] [Related]
13. Antirejection drugs and procedures.
Chatterjee SN
Am J Surg; 1973 Nov; 126(5):678-82. PubMed ID: 4129988
[No Abstract] [Full Text] [Related]
14. Treatment of steroid resistant acute rejection after renal transplantation.
Oh CK; Kim YS; Kim MS; Kim SI; Park K
Transplant Proc; 1996 Jun; 28(3):1453-4. PubMed ID: 8658737
[No Abstract] [Full Text] [Related]
15. Relationship of iris nevi to malignant melanoma of the uvea.
Michelson JB; Shields JA
Am J Ophthalmol; 1977 May; 83(5):694-6. PubMed ID: 868968
[TBL] [Abstract][Full Text] [Related]
16. [Immunosuppressive treatment in renal homologous transplantation].
Mazzei D; Vallino F; Civardi F
Minerva Chir; 1975 Aug 15-31; 30(15-16):866-73. PubMed ID: 772470
[No Abstract] [Full Text] [Related]
17. Immunosuppressive drugs used in clinical renal transplantation.
Chatterjee SN
Urology; 1977 Jun; 9(6 Suppl):52-60. PubMed ID: 70101
[No Abstract] [Full Text] [Related]
18. Tacrolimus therapy for ABO-incompatible kidney transplantation.
Takahashi K; Saito K; Sonda K; Nakagawa Y; Katagiri A; Tomita Y; Tanigawa T; Takeda M
Transplant Proc; 1998 Jun; 30(4):1219-20. PubMed ID: 9636495
[No Abstract] [Full Text] [Related]
19. The role of immunosuppression in the genesis and growth of malignant tumours.
Reis HE
Ger Med Mon; 1971; 1(1):16-21. PubMed ID: 4931500
[No Abstract] [Full Text] [Related]
20. Effect of duration of MALG therapy in a quadruple immunosuppressive protocol.
Stratta RJ; D'Alessandro AM; Armbrust MJ; Pirsch JD; Sollinger HW; Kalayoglu M; Belzer FO
Transplant Proc; 1989 Feb; 21(1 Pt 2):1726-8. PubMed ID: 2652564
[No Abstract] [Full Text] [Related]
[Next] [New Search]
